Fisher & Paykel reports 39% 1H profit increase, lifts FY guidance

Fisher & Paykel Healthcare has reported strong growth for the first half of the 2026 financial year, with a 39% increase in net profit.

Total operating revenue reached $1.09 billion, up 14% from the same period last year.

In constant currency terms, revenue increased by 12%.

Net profit after tax was $213.0 million, an increase of 39% over the first half of the prior financial year, or 28% in constant currency.

The company's Hospital product group, which includes humidification products used in respiratory, acute, and surgical care, reported a 17% increase in first-half revenue, while the Homecare product group, which includes products for the treatment of obstructive sleep apnea and respiratory support in the home, had a 10% increase in revenue.

Fisher & Paykel Healthcare's directors have approved an interim dividend of 19 cents per ordinary share, up from 18.5 cents per share in the first half of the prior year.

Looking ahead, the company now expects full-year operating revenue to be in the range of $2.17 billion to $2.27b and full-year net profit after tax to be in the range of $410m to $460m.